Ophthalmology Product Guide » Durezol http://www.ophthalmologyproductguide.com/blog A comprehensive guide to ophthalmology products for medical professionals Fri, 11 Jun 2010 12:36:57 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 Alcon Buys Rights For Durezol and Zirgan http://www.ophthalmologyproductguide.com/blog/2010/01/28/alcon-buys-rights-for-durezol-and-zirgan/ http://www.ophthalmologyproductguide.com/blog/2010/01/28/alcon-buys-rights-for-durezol-and-zirgan/#comments Thu, 28 Jan 2010 05:07:18 +0000 Jim Marino http://www.ophthalmologyproductguide.com/blog/?p=201 DurezolAlcon has bought rights for and Zirgan from Sirion Therapeutics Inc. for an undisclosed amount. While Durezol is an ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, Zirgan is an antiviral for the treatment of corneal ulcers. Both products have been approved by the Food and Drug Administration.

Alcon said it has acquired the global rights, excluding Latin America, for Zyclorin, which is being developed as a potential treatment for dry eyes and other diseases.

Alcon Buys Rights For Durezol and Zirgan

Alcon has bought rights for Durezol and Zirgan from Sirion Therapeutics Inc. for an undisclosed amount. While Durezol is an ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, Zirgan is an antiviral for the treatment of corneal ulcers. Both products have been approved by the Food and Drug Administration.

Alcon said it has acquired the global rights, excluding Latin America, for Zyclorin, which is being developed as a potential treatment for dry eyes and other diseases.

]]> http://www.ophthalmologyproductguide.com/blog/2010/01/28/alcon-buys-rights-for-durezol-and-zirgan/feed/ 0 Data from comparative trial involving Durezol and Pred Forte http://www.ophthalmologyproductguide.com/blog/2008/10/17/durezol-as-effective-as-pred-forte-trial/ http://www.ophthalmologyproductguide.com/blog/2008/10/17/durezol-as-effective-as-pred-forte-trial/#comments Fri, 17 Oct 2008 10:08:07 +0000 Jim Marino http://www.ophthalmologyproductguide.com/blog/2008/10/17/durezol-as-effective-as-pred-forte-trial/ Sirion Therapeutics, Inc. has released results of a comparative trial evaluating the efficacy of Durezol(TM) 0.05% dosed four times daily against Allergan’s Pred Forte(R) 1%, dosed eight times daily. A topical ophthalmic corticosteroid, Durezol was indicated by the FDA in June 2008 for treating pain and inflammation related to ocular surgery. At the end of two weeks, the Durezol group achieved a mean cell grade reduction of 2.1, compared to 1.9 in the Pred Forte group, showing the potential of Durezol as a steroid.

]]> http://www.ophthalmologyproductguide.com/blog/2008/10/17/durezol-as-effective-as-pred-forte-trial/feed/ 0 FDA grants Durezol priority review status http://www.ophthalmologyproductguide.com/blog/2008/03/07/fda-grants-durezol-priority-review-status/ http://www.ophthalmologyproductguide.com/blog/2008/03/07/fda-grants-durezol-priority-review-status/#comments Fri, 07 Mar 2008 16:15:50 +0000 Jim Marino http://www.ophthalmologyproductguide.com/blog/2008/03/07/fda-grants-durezol-priority-review-status/ Sirion Therapeutics Inc. hSiron Therapeutics Logoas received FDA approval for its New Drug Application (NDA) for Durezol(TM). The FDA has granted the drug priority review, which means that the review would be completed in six months from the date of receipt of the NDA. The NDA is for Sirion Therapeutics’ investigational compound Durezol(TM) (difluprednate ophthalmic emulsion) 0.05%, a twice-daily steroid, as a treatment for postoperative ocular inflammation.

]]> http://www.ophthalmologyproductguide.com/blog/2008/03/07/fda-grants-durezol-priority-review-status/feed/ 0